Overall market sentiment has been high on Gossamer Bio Inc (GOSS) stock lately. GOSS receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Gossamer Bio Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on GOSS!
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With GOSS Stock Today?
Gossamer Bio Inc (GOSS) stock is trading at $0.82 as of 3:08 PM on Wednesday, Nov 15, a gain of $0.19, or 30.93% from the previous closing price of $0.62. The stock has traded between $0.66 and $0.83 so far today. Volume today is above average. So far 3,434,415 shares have traded compared to average volume of 2,100,501 shares.
To see InvestorsObserver's Sentiment Score for Gossamer Bio Inc click here.
More About Gossamer Bio Inc
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Click Here to get the full Stock Report for Gossamer Bio Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
